A new issue of AMJ Respiratory provides healthcare professionals with a direct distillation of key findings from the American Thoracic Society's 2026 conference.
The publication focuses on evidence-based shifts in clinical practice, particularly for severe asthma and chronic obstructive pulmonary disease (COPD).
Highlights include a twice-yearly injection that is transforming biological therapy for severe asthma and the implementation of personalized, technology-enabled care protocols for COPD management.
The journal features 110 pages of emerging research, supported by analysis from over 80 leading respiratory experts. It is available as a free, open-access resource for practitioners in pulmonary medicine.